0000899243-16-012542.txt : 20160202 0000899243-16-012542.hdr.sgml : 20160202 20160202163051 ACCESSION NUMBER: 0000899243-16-012542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160201 FILED AS OF DATE: 20160202 DATE AS OF CHANGE: 20160202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hooks Corwin Dale CENTRAL INDEX KEY: 0001665347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 161381255 MAIL ADDRESS: STREET 1: C/O CLOVIS ONCOLOGY, INC. STREET 2: 5500 FLATIRON PARKWAY CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001665347 Hooks Corwin Dale C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY BOULDER CO 80301 0 1 0 0 See Remarks Stock option (right to buy) 20.90 2016-02-01 4 A 0 10000 0.00 A 2026-02-01 Common Stock 10000 10000 D Stock option (right to buy) 20.90 2016-02-01 4 A 0 10000 0.00 A 2026-02-01 Common Stock 10000 10000 D The option shall vest as to 25% of the shares on February 1, 2017, and the remainder shall vest in substantially equal installments over the 48 months immediately following such date. The option shall vest as to 50% of the shares on February 1, 2017, and the remainder shall vest on February 1, 2018. Senior Vice President and Chief Commercial Officer /s/ Corwin Dale Hooks 2016-02-01